
Why Drug Development Needs a Data Foundation - Life Sciences Today Podcast Episode 87
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ganesh Nathella, EVP and Global Head of Healthcare and Life Sciences at Persistent Systems. Nathella and I discuss how Persistent Systems combines life sciences expertise with data engineering and AI to support pharma, CRO, and medtech customers. We examine whether clinical data infrastructure should be treated as core IP, why one-off AI projects are an industry anti-pattern, and what it will take to move AI from pilots into clinical workflows.
Check out the main topics of discussion for this episode of the Life Sciences Today podcast:
- How did you come to lead Persistent’s global healthcare and life sciences business?
- What does combining science and engineering let Persistent do for customers?
- When does Persistent use fixed-price programs, managed services, outcome-based work, or time-and-material engagements?
- Why would a customer choose an engineering partner rather than an established clinical software product?
- If clinical data is valuable to pharma companies, why do CROS handle so much of the trial execution? What would better data integration require?
- What goes wrong when every AI initiative is treated as a one-off project?
- Where can AI improve drug development, and where do biology and clinical operations still set limits?
- What uncertainty during COVID most changed your view of the business?
- What is the biggest anti-pattern in your industry?
Subscribe to Danny’s newsletter to get strategic patterns for life science leaders building a defensible business.
Be sure to subscribe to the Life Sciences Today Podcast on your favorite podcasting platform:
Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube. Plus, all of the audio and video versions will be made available to stream on Healthcare IT Today. As a former pharma-tech founder who bootstrapped to exit, I now help TechBio and digital health CEOs grow revenue—by solving the tech, team, and go-to-market problems that stall your progress. If you want a warrior by your side, connect with me on LinkedIn.
If you work in Life Sciences IT, we’d love to hear where you agree and/or disagree with our takes on health IT innovation in life sciences. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes.
Thanks so much for listening!
Weitere Episoden von „Life Sciences Today“



Verpasse keine Episode von “Life Sciences Today” und abonniere ihn in der kostenlosen GetPodcast App.








